Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

May 17, 2016
Otsuka Holdings

Notification of Change of Equity Method Affiliate (Transfer of Shares)
May 16, 2016
Otsuka Holdings

Otsuka Holdings Announces Collaboration with ReCor Medical for Commercialization of ReCor Medical’s Ultrasound Renal Denervation Technology in Asia
May 13, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters Into Comprehensive Partnership Agreement with Osaka Prefecture
May 13, 2016
Otsuka Holdings

Issuance of Share Remuneration-type Stock Options (Share Acquisition Rights)
May 10, 2016
Taiho Pharmaceutical

Taiho Pharmaceutical Forms Taiho Ventures to Foster Oncology Biotech Start-ups
May 10, 2016
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory and Lilium Otsuka sign Japanese-market sales partnership agreement for Otsuka Pharmaceutical Factory and Lilium Otsuka sign Japanese-market sales partnership agreement for the medical device “Lilium® α-200”
May 9, 2016
Otsuka Pharmaceutical

Introducing Three New Flavors of Calorie Mate Jelly Focusing on the Need for a Nutritionally Balanced Jelly Beverage Option
April 28, 2016
Taiho Pharmaceutical

Patients with Advanced Metastatic Colorectal Cancer in Europe Now Have New Treatment Option as LONSURF® (trifluridine/tipiracil) Receives EU Approval
April 27, 2016
Otsuka Pharmaceutical

FDA Issues Complete Response Letter For Digital Medicine New Drug Application
April 26, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Health Promotion Partnership with Kagoshima Prefecture
April 22, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Comprehensive Partnership with Mie Prefecture
April 21, 2016
Otsuka Pharmaceutical

Otsuka receives two commendations by the Japanese Government for the development of an anti-tuberculosis agent and an aquaretic/ADPKD treatment
April 20, 2016
Otsuka Pharmaceutical

Otsuka's U.S. Subsidiary Astex Pharmaceuticals Enters Clinical Trial Collaboration to Explore the Potential of Combining Guadecitabine (SGI-110) with Atezolizumab in the Treatment of Acute Myeloid Leukemia
April 12, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Launches "POCARI SWEAT & TOKYO Project" in Cooperation with Tokyo Metropolitan Government
April 11, 2016
Taiho Pharmaceutical

Tiovita series to go on sale outside Japan Tiovita 3000 to Be Released in Hong Kong "Supporting the hard workers of Hong Kong"
April 11, 2016
Taiho Pharmaceutical

MSD and Taiho Enter into Co-Promotion Agreement in Japan for Pembrolizumab, MSD’s Immune Checkpoint Inhibitor (Anti-PD-1 Therapy)
April 4, 2016
Otsuka Pharmaceutical

New POCARI SWEAT Jelly for "Edible Hydration" First new form of POCARI SWEAT since initial launch 36 years ago
April 1, 2016
Otsuka Pharmaceutical

Thirst-quenching beverage aims to help women maintain optimum day-to-day condition Renewed Version of POCARI SWEAT Ion Water
April 1, 2016
Taiho Pharmaceutical

Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in Asian Patients with Refractory Metastatic Colorectal Cancer
March 31, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Signs Health Promotion Support Agreement with Hyogo Prefecture
March 30, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters Into Comprehensive Partnership with Hiroshima Prefecture
March 30, 2016
Otsuka Holdings

Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members
March 28, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Disaster Relief Supply Agreement with Ishikawa Prefecture
March 16, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters Into Health Promotion Partnership with Okayama Prefecture
March 15, 2016
Otsuka Pharmaceutical

New casual soy bar with the pleasant crunchy texture of puffed soy "SOYJOY Crispy" Debuts in Three Flavors
March 15, 2016
Taiho Pharmaceutical

Taiho Pharmaceutical Announces Personnel Changes
March 11, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Supports 37,000 Runners with Nutritional and Rehydration Products and Cadre of Blue Volunteers at Tokyo Marathon 2016
March 8, 2016
Otsuka Pharmaceutical

Otsuka Pharmaceutical Co., Ltd. Appoints Board Members and Statutory Auditors
March 2, 2016
Otsuka Pharmaceutical

ABILIFY for Extended Release Injectable Suspension, Used to treat Schizophrenia, Has Received Approval in Japan for Administration at Deltoid Muscle Site
March 2, 2016
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory, Inc. changes the flavor and packaging of its Oral Rehydration Solution OS-1®